An adjuvanted subunit SARS-CoV-2 spike protein vaccine provides protection against Covid-19 infection and transmission

Recombinant protein approaches offer major promise for safe and effective vaccine prevention of SARS-CoV-2 infection. We developed a recombinant spike protein vaccine (called NARUVAX-C19) and characterized its ability when formulated with a nanoemulsion adjuvant to induce anti-spike antibody and T-c...

Descripción completa

Detalles Bibliográficos
Autores principales: Tabynov, Kairat, Turebekov, Nurkeldi, Babayeva, Meruert, Fomin, Gleb, Yerubayev, Toktassyn, Yespolov, Tlektes, Li, Lei, Renukaradhya, Gourapura J., Petrovsky, Nikolai, Tabynov, Kaissar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8866462/
https://www.ncbi.nlm.nih.gov/pubmed/35197485
http://dx.doi.org/10.1038/s41541-022-00450-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8866462/
https://www.ncbi.nlm.nih.gov/pubmed/35197485
http://dx.doi.org/10.1038/s41541-022-00450-8

Ejemplares similares